Charles River Laboratories (CRL)
Debt-to-equity ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 3,596,880 | 3,305,990 | 3,251,700 | 3,108,600 | 2,976,290 | 2,626,850 | 2,647,710 | 2,610,180 | 2,534,820 | 2,426,570 | 2,318,440 | 2,183,930 | 2,114,600 | 1,896,940 | 1,752,640 | 1,651,980 | 1,634,580 | 1,532,310 | 1,455,070 | 1,398,110 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $3,596,880K
= 0.00
Based on the data provided for Charles River Laboratories' debt-to-equity ratio from the past 20 quarters, the ratio consistently appears as 0.00. A debt-to-equity ratio of 0.00 indicates that the company has no financial leverage and is entirely financed by equity. In this case, Charles River Laboratories does not have any debt in its capital structure. This can be seen as a positive indicator of financial stability and independence from debt-related risks. However, it's important to note that while a low debt-to-equity ratio is generally favorable, a company may benefit from a reasonable amount of debt to finance growth opportunities and tax advantages.
Peer comparison
Dec 31, 2023